Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 7, 2010, Pages 1547-1554

  Nossent, A Y ^a,b,c,d   Robben, J H ^e   Deen, P M T ^e   Vos, H L ^a,b   Rosendaal, F R ^a,b   Doggen, C J M ^b   Hansen, J L ^c,d   Sheikh, S P ^d   Bertina, R M ^a,b   Eikenboom, H C J ^a,b  

^a Einthoven Laboratory for Experimental Vascular Medicine   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arginine vasopressin 2 receptor; Coagulation factor VIII; SNP; Von Willebrand factor; Von Willebrand factor propeptide

Indexed keywords

ARGIPRESSIN; CYCLIC AMP; GREEN FLUORESCENT PROTEIN; VASOPRESSIN V2 RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; DISSOCIATION CONSTANT; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA;

ALLELES; ANIMALS; ARGININE VASOPRESSIN; DOGS; FACTOR VIII; GENETIC VARIATION; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; PROTEIN BINDING; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION; VON WILLEBRAND FACTOR;

EID: 77955047970     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03884.x     Document Type: Article

References (22)

1. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom HC, Bertina RM, Rosendaal FR. Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 1998, 79:323-7.
2. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, Eikenboom JC, Harvey M, Bertina RM, Rosendaal FR. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000, 109:519-22.
3. De Visser MC, Sandkuijl LA, Lensen RP, Vos HL, Rosendaal FR, Bertina RM. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci. J Thromb Haemost 2003, 1:1771-6.
4. Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001, 16:1146-52.
5. Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000, 106:107-16.
6. Mannucci PM. Desmopressin (DDAVP) for treatment of disorders of hemostasis. Prog Hemost Thromb 1986, 8:19-45.
7. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986, 46:185-90.
8. Tsai HM, Nagel RL, Hatcher VB, Seaton AC, Sussman II. The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway. Br J Haematol 1991, 79:239-45.
9. Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von Willebrand factor from human endothelial cells. Blood 2008, 112:957-64.
10. Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJ, Pasterkamp G, Meijer-Huizinga F, Zwart-Huinink L, Voorberg J, van Mourik JA. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 1996, 88:2951-8.
11. van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, van Genderen PJ, Fijnheer R. von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999, 94:179-85.
12. Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, Haefeli WE, Kruithof EK. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) levels. Thromb Haemost 1997, 77:387-93.
13. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993, 342:1503-6.
14. van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997, 78:631-5.
15. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995, 345:152-5.
16. Nossent AY, van Marion V, van Tilburg NH, Rosendaal FR, Bertina RM, van Mourik JA, Eikenboom HC. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost 2006, 4:2556-62.
17. Doggen CJ, Kunz G, Rosendaal FR, Lane DA, Vos HL, Stubbs PJ, Manger Cats V, Ireland H. A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men. Thromb Haemost 1998, 80:743-8.
18. Robben JH, Knoers NV, Deen PM. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model. Am J Physiol Renal Physiol 2005, 289:F265-72.
19. Deen PM, Van Balkom BW, Savelkoul PJ, Kamsteeg EJ, Van Raak M, Jennings ML, Muth TR, Rajendran V, Caplan MJ. Aquaporin-2: COOH terminus is necessary but not sufficient for routing to the apical membrane. Am J Physiol Renal Physiol 2002, 282:F330-40.
20. Robben JH, Knoers NV, Deen PM. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 2004, 15:5693-9.
21. Nossent AY, Eikenboom HC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM, Rosendaal FR. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis. Thromb Haemost 2006, 95:942-8.
22. Nossent AY, Eikenboom HC, Tanis BC, Doggen CJ, Rosendaal FR. Haplotypes encoding the factor VIII 1241Glu variation and the risk of myocardial infarction. J Thromb Haemost 2007, 5:619-21.